Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
1995 |
| gptkbp:ATCCode |
A10BB12
|
| gptkbp:contraindication |
gptkb:diabetic_ketoacidosis
type 1 diabetes |
| gptkbp:drugClass |
sulfonylurea
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericName |
gptkb:glimepiride
|
| gptkbp:halfLife |
5-8 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Amaryl
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:mechanismOfAction |
stimulates insulin release from pancreatic beta cells
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:hypoglycemia
nausea dizziness weight gain |
| gptkbp:usedFor |
gptkb:type_2_diabetes_mellitus
|
| gptkbp:bfsParent |
gptkb:Sanofi
|
| gptkbp:bfsLayer |
5
|